Head and neck region consolidation radiotherapy and prophylactic cranial irradiation with hippocampal avoidance delivered with helical tomotherapy after induction chemotherapy for non-sinonasal neuroendocrine carcinoma of the upper airways

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Franco, Pierfrancesco ^a   Numico, Gianmauro ^a   Migliaccio, Fernanda ^a   Catuzzo, Paola ^a   Cante, Domenico ^a,b   Ceroni, Paola ^a   Sciacero, Piera ^a,b   Carassai, Pierpaolo ^a   Canzi, Paolo ^a   La Porta, Maria R ^a,b   Girelli, Giuseppe ^a,b   Borca, Valeria C ^a,b   Pasquino, Massimo ^a,b   Tofani, Santi ^a,b   Ozzello, Franca ^a   Ricardi, Umberto ^c  

^a Ospedale Regionale 'U Parini'   (Italy)

^b Ospedale di Ivrea   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

Head and neck; Hippocampus avoidance; Non sinonasal neuroendocrine carcinoma; Prophylactic cranial irradiation; Radiotherapy; Tomotherapy

Indexed keywords

CD56 ANTIGEN; CHROMOGRANIN A; CISPLATIN; CYTOKERATIN AE1; CYTOKERATIN AE3; ETOPOSIDE; ANTINEOPLASTIC AGENT;

ADULT; ALOPECIA; ARTICLE; ASTHENIA; BRAIN RADIATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONSOLIDATION CHEMOTHERAPY; DRUG DOSE REGIMEN; FOLLOW UP; HEAD AND NECK CANCER; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; LARYNGOSCOPY; MALE; MUCOSA INFLAMMATION; NASOPHARYNX; NEUROENDOCRINE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PROPHYLAXIS; PUNCH BIOPSY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SKIN MANIFESTATION; SMALL CELL CARCINOMA; TOMOTHERAPY; TONSIL DISEASE; TONSILLECTOMY; TONSILLITIS; TREATMENT DURATION; TREATMENT PLANNING; UPPER RESPIRATORY TRACT; XEROSTOMIA; CARCINOMA; CONSERVATIVE TREATMENT; HEAD AND NECK TUMOR; INDUCTION CHEMOTHERAPY; MIDDLE AGED; REMISSION; RESPIRATORY TRACT TUMOR; SKULL IRRADIATION; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SQUAMOUS CELL; CISPLATIN; CRANIAL IRRADIATION; ETOPOSIDE; HEAD AND NECK NEOPLASMS; HIPPOCAMPUS; HUMANS; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; ORGAN SPARING TREATMENTS; REMISSION INDUCTION; RESPIRATORY TRACT NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84856997193     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-21     Document Type: Article

References (23)

1. Barker JL, Glisson BS, Garden AS, et al. Management of nonsinonasal neuroendocrine carcinomas of the head and neck. Cancer 2003, 98:2322-2328. 10.1002/cncr.11795, 14635065.
2. Ibrahim NBN, Briggs JC, Corbyshley CM. Extrapulmonary oat cell carcinoma. Cancer 1984, 54:1645-1661. 10.1002/1097-0142(19841015)54:8<1645::AID-CNCR2820540828>3.0.CO;2-Q, 6089995.
3. Mills SE. Neuroendocrine tumors of the head and neck: a selected review with emphasis on terminology. Endocr Pathol 1996, 7:329-343. 10.1007/BF02739841, 12114805.
4. Likhacheva A, Rosenthal DI, Hanna E, Kupferman M, DeMonte F, El-Naggar AK. Sinonasal neuroendocrine carcinoma: impact of differentiation status on response and outcome. Head and Neck Oncology 2011, 3:32. 10.1186/1758-3284-3-32, 3154852, 21794118.
5. Capelli M, Bertino G, Morbini P, Villa C, Zorzi S, Benazzo M. Neuroendocrine carcinomas of the upper airways: a small case series with histopatological considerations. Tumori 2007, 93:499-503.
6. Brisigotti M, Fabretti G, Lanzanova G, Brugnari ER, Presutti L, Artoni S. Atypical carcinoid of the larynx: case report. Tumori 1987, 73:417-421.
7. Procopio G, Ricotta R, Fusi A, et al. Neuroendocrine tumors of the larynx: a clinical report and literature review. Tumori 2006, 92:72-75.
8. Gondi V, Tomé W, Metha MP. Why avoid the hippocampus? A Review. Radiother Oncol 2010, 97:370-376. 10.1016/j.radonc.2010.09.013, 2997490, 20970214.
9. Robbins KT. Integrating radiological criteria into the classification of cervical lymph node disease. Arch Otolaryngol Head Neck Surg 1999, 125:385-387.
10. Gondi V, Tolakanahalli R, Mehta MP, et al. Hippocampal-sparing whole-brain radiotherapy: a 'How-to' technique using helical tomotherapy and linear-accellerator-based intensity-modulated radiotherapy. Int J Radiat Oncol Bio Phys 2010, 78:1244-1252.
11. Rancati T, Schwarz M, Allen AM, et al. Radiation dose-volume effects in the larynx and pharynx. Int J Radiat Oncol Biol Phys 2010, 76:S64-S69. 10.1016/j.ijrobp.2009.03.079, 2833104, 20171520.
12. Deasey JO, Moiseenko V, Marks L, Chao C, Nam J, Eisbruch A. Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys 2010, 76:S58-S63. 10.1016/j.ijrobp.2009.06.090, 20171519.
13. Bhandare N, Jackson A, Eisbruch A, et al. Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys 2010, 76:S50-S57. 10.1016/j.ijrobp.2009.04.096, 20171518.
14. Mayo C, Martel MK, Marks LB, Flickinger J, Nam J, Kirkpatrick J. Radiation dose-volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys 2010, 76:S28-S35. 10.1016/j.ijrobp.2009.07.1753, 20171514.
15. Corvo' R. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiother Oncol 2007, 85:156-170. 10.1016/j.radonc.2007.04.002, 17482300.
16. Boushey RP, Dackwick AP. Carcinoid tumors. Curr Treat Options Oncol 2002, 3:319-326. 10.1007/s11864-002-0031-2, 12074768.
17. Jassem J. The role of radiotherapy in lung cancer: where is the evidence?. Radiother Oncol 2007, 83:203-213. 10.1016/j.radonc.2007.04.004, 17482301.
18. Mackie TR, Balog J, Ruchala K, et al. Tomotherapy. Semin Radiat Oncol 1999, 9:108-117. 10.1016/S1053-4296(99)80058-7, 10210549.
19. Mackie TR, Holmes T, Swerdloff S, et al. Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Med Phys 1993, 20:1709-1719. 10.1118/1.596958, 8309444.
20. Meyers CA, Brown PD. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumours. J Clin Oncol 2006, 24:1305-1309. 10.1200/JCO.2005.04.6086, 16525186.
21. Gondi V, Tome WA, Marsh J, et al. Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933. Radiother Oncol 2010, 95:327-331. 10.1016/j.radonc.2010.02.030, 2981132, 20392503.
22. Meyers CA, Wefel JS. The use of the mini-mental status examnation to assess cognitive function in cancer trials: no ifs, ands, buts or sensitivity. J Clin Oncol 2003, 21:3557-3558. 10.1200/JCO.2003.07.080, 12913103.
23. Scoccianti S, Ricardi U. Treatment of brain metastasis: review of phase III randomized trials. Radiother Oncol http://dx.doi.org/10.1016/j.bbr.2011.03.031.